Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

coronary thrombosis/asthenia

Link salvestatakse lõikelauale
ArtiklidKliinilistes uuringutesPatendid
4 tulemused

[Results of the surgical treatment of urinary incontinence in women. A homogenous series of 293 operations].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The statistic from 278 cases of urinary incontinence in women in a gynaecological department are reported. There was one unexpected death (from coronary thrombosis) and one hemiplegia. From the remaining cases althogether 5-7 p. 100 failures, 7-9 p. 100 partial successes and 86.5 p. 100 cures. The

Rivaroxaban Rebound Acute Coronary Event: A Post Marketing Experience.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We present a 65-year-old male who received rivaroxaban therapy prior to and after left knee replacement surgery. The patient developed generalized weakness soon after stopping rivaroxaban. An electrocardiogram showed acute infero-lateral ischemia and an echocardiogram reported an akinetic

Mediterranean diet in secondary prevention of CHD.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE To summarise our present knowledge on the Mediterranean diet in secondary prevention of CHD. METHODS Review of literature. METHODS Adult coronary patients. METHODS CHD patients at high risk of cardiac death. RESULTS The two main causes of death in these patients are sudden cardiac death

[Neuroborreliosis in patient with aplastic anaemia secondary to therapy with ticlopidine].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Aplastic anaemia is a rare but potentially fatal complication of treatment with ticlopidine. METHODS We present a 55-year-old male with aplastic anaemia which developed after 45 days of the therapy with 200 mg ticlopidine to prevent coronary thrombosis. The treatment with ticlopidine was
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge